QT Sense
QT Sense is a Netherlands-based spinout from University Medical Center Groningen that develops the Quantum Nuova benchtop platform using fluorescent nanodiamond quantum sensors to detect free radicals in living cells in real time, serving academic researchers and pharmaceutical R&D teams.
- Company typePrivate
- Founded2024
- HeadquartersGroningen, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
QT Sense firmographics
Firmographics- Name
- QT Sense
- Legal name
- QT Sense BV
- Website
- https://qtsense.com
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- QT Sense is a Netherlands-based spinout from University Medical Center Groningen that develops the Quantum Nuova benchtop platform using fluorescent nanodiamond quantum sensors to detect free radicals in living cells in real time, serving academic researchers and pharmaceutical R&D teams.
- Ownership category
- akta.pro rank
QT Sense industry classification
Industry- Product category
- Quantum Biosensing Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Quantum Spectroscopy & Chemical/Biological Sensing (HDAGAHAH)
Keywords
Where QT Sense is headquartered
LocationHeadquarters
- HQ city
- Groningen
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
QT Sense business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Quantum Nuova Instrument Sales: Sale of the Quantum Nuova quantum biosensing platform hardware and system to research institutions, pharmaceutical companies, and healthcare facilities for drug discovery and diagnostic research applications.
- Training and Support Services: Hands-on training sessions, technical support, and ongoing customer success services including installation, validation, and application guidance for the Quantum Nuova platform.
- Research Collaborations: Collaborative research projects with academic and clinical partners, potentially including grant-funded research initiatives such as the ONCO-Q project for colorectal cancer diagnostics.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels6 records
QT Sense product offering
Product offeringCore offering
QT Sense develops and sells the Quantum Nuova platform, a benchtop quantum biosensing instrument that uses fluorescent nanodiamond sensors with Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at subcellular resolution in real time. The system is paired with Quantum Pulse proprietary software for instrument control and data analysis, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research. Installation, validation, hands-on training, and ongoing customer support are provided as part of the offering.
Product overview
QT Sense offers Quantum Nuova as its core flagship product—a quantum biosensing platform that combines fluorescent nanodiamond quantum sensors (containing NV centers) with advanced optics and embedded control systems to enable real-time, subcellular detection of free radicals in living cells. The platform is complemented by Quantum Pulse Software, which provides instrument control and automated data analysis. Together, these products enable researchers to monitor cellular stress, oxidative stress, and metabolic changes at single-cell resolution for applications in drug discovery, cancer research, sepsis diagnostics, and cardiovascular disease research.
Differentiator
Problem solved
Functional benefit
Brands
- Quantum Nuova: A high-resolution biosensing platform that uses fluorescent nanodiamond quantum sensors to detect free radicals and oxidative stress in living cells at single-cell resolution in real time, enabling applications in drug discovery, cancer research, and diagnostics.
Products and services
- Quantum Nuova A high-resolution quantum biosensing platform that uses fluorescent nanodiamond sensors containing Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at single-cell and subcellular resolution in real time. It enables real-time monitoring of oxidative stress, metabolic shifts, and cellular stress responses, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research.
Quantifiable outcome
- Detects free radicals at nanomolar concentrations (1-10nM detection limits)
- +5 more outcomes
Companies that use QT Sense
Customer profileNamed customers6 records
Segments7 records
Ideal customer profiles3 records
QT Sense technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
QT Sense partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and emerging.
- Leiden UniversitycoreFirst installation of QT Sense's quantum biosensor installation at Leiden with Dr. Alireza Mashaghi's laboratory, enabling detection of rapid chemical changes in cells for drug discovery research.
- University of GroningencorePartner in the ONCO-Q €2M JTF-funded project for precision oncology diagnostics using quantum sensing technology.
- Healthy Ageing Business CooperativecorePartner in the ONCO-Q project consortium focused on advancing colorectal cancer diagnostics through quantum sensing.
- University Medical Center Groningen (UMCG)coreUMCG's Emergency Department installed Quantum Nuova in September 2025 for sepsis research under Prof. Hjalmar Bouma's leadership. UMCG is QT Sense's founding institution as a spinout. Also collaborates on ONCO-Q €2M project for colorectal cancer diagnostics.
- Ravi Puvvala (Bangalore, India)emergingPartnership with Bangalore-based researcher Ravi Puvvala's group for first Indian deployment of Quantum Nuova platform, focusing on real-time radical sensing applications.
- Dr. Swaminathan (Tata IISc Medical School)emergingCollaboration with Tata IISc Medical School focusing on conditions like sepsis and acute kidney injury in India, exploring quantum biosensing applications.
- Quantum Delta NLcorePart of the Stichting QDNL (Quantum Delta NL) ecosystem, a €615 million Dutch National Growth Fund programme establishing the Netherlands as a global leader in quantum technology. QT Sense is among the first applications from this initiative.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
QT Sense competitors and assessment
Company assessmentDirect peers
- Qnami: Qnami develops quantum sensing instruments based on NV centers in diamond for nanoscale magnetic imaging and biosensing. It is the most direct comparable to QT Sense in using diamond quantum sensors for life-science and bio-magnetic applications.
Broad incumbents
- Bruker: Bruker is a global analytical instruments leader spanning EPR (electron paramagnetic resonance) spectrometers and preclinical imaging systems, which overlap directly with QT Sense's free radical detection use case. It is the incumbent reference standard that QT Sense positions against in life-sciences research labs.
- Thermo Fisher Scientific: Thermo Fisher is the dominant analytical and life-sciences instrumentation company, providing flow cytometers, high-content imaging, and reagents used in cellular stress and oxidative stress research. It is the benchmark enterprise vendor QT Sense will compete with for pharma and biotech research budgets.
- Agilent Technologies: Agilent manufactures a broad range of analytical instruments (mass spec, chromatography, cell analysis) used by pharma and biotech research labs. It is relevant as a broad incumbent competitor for cellular analytical workflows that QT Sense targets.
- Oxford Instruments (Andor): Oxford Instruments' Andor division supplies high-sensitivity cameras, microscopy, and spectroscopy systems used in advanced bio-imaging and quantum sensing setups. It is comparable as a supplier of optical and detection instrumentation underpinning quantum biosensing research.
- Sartorius: Sartorius provides cell analysis instruments and bioprocessing tools widely used in pharmaceutical R&D and cell-based assays. It is comparable as an incumbent life-sciences instrumentation vendor whose installed base QT Sense must displace for cell-based drug discovery applications.
- Carl Zeiss (ZEISS Research Microscopy Solutions): ZEISS produces advanced optical microscopes and imaging platforms used in subcellular and live-cell imaging. Its super-resolution and confocal systems are an incumbent reference for the kind of high-resolution cellular analysis that Quantum Nuova is positioned to complement or substitute.
- PerkinElmer (Revvity): PerkinElmer/Revvity offers life-sciences reagents, imaging, and analytical instruments used in cell biology, oxidative stress, and diagnostics research. It is a broad incumbent peer in the analytical tools category serving QT Sense's target academic and pharma customers.
Emerging players
- Quantum Diamonds (QDTI): Quantum Diamonds is a deep-tech startup building quantum sensing solutions based on NV centers in diamond for biomedical and industrial applications. It is an emerging peer with overlapping technology roots and target applications in magnetic and biosensing.
Others
- Adamas Nanotechnologies: Adamas Nanotechnologies is a leading manufacturer of fluorescent nanodiamonds (FNDs) used as the core sensing element in QT Sense's platform. It is a key enabling supplier and ecosystem partner rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
QT Sense social profiles
Digital presenceQT Sense financial estimates
Financial estimateRevenue estimate
Valuation estimate
QT Sense leadership team
Management profileNumber of profiles
Profiles2 records
QT Sense funding detail
Funding detailFunding overview
Funding rounds5 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
QT Sense M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about QT Sense
What does QT Sense do?
QT Sense develops and sells the Quantum Nuova platform, a benchtop quantum biosensing instrument that uses fluorescent nanodiamond sensors with Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at subcellular resolution in real time. The system is paired with Quantum Pulse proprietary software for instrument control and data analysis, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research. Installation, validation, hands-on training, and ongoing customer support are provided as part of the offering.
Is QT Sense a public or private company?
QT Sense is a private company. It is classified as venture growth investor backed and is currently operating.
When was QT Sense founded?
QT Sense was founded in 2024. It employs 1 to 10 people.
Where is QT Sense based?
QT Sense is headquartered in Groningen, Netherlands, in the Europe region.
How does QT Sense make money?
Three revenue lines are on record. Quantum Nuova Instrument Sales are the primary driver. The others are training and Support Services and research Collaborations.
Who are QT Sense's main competitors?
Qnami is listed as a direct peer. Broad incumbents are Bruker, Thermo Fisher Scientific, Agilent Technologies, Oxford Instruments (Andor), Sartorius, Carl Zeiss (ZEISS Research Microscopy Solutions) and PerkinElmer (Revvity). Quantum Diamonds (QDTI) is listed as an emerging player. Adamas Nanotechnologies is listed as an others.
Does QT Sense have an API?
No public API is recorded for QT Sense.
What industry is QT Sense in?
QT Sense's product category is Quantum Biosensing Instruments. Its primary akta.pro industry code is HDAGAHAH, Quantum Spectroscopy & Chemical/Biological Sensing. Its NAICS code is 334516 and its SIC code is 3826.